Roche is shutting down its research and development efforts in semiconductor sequencing and nanopore sequencing and is consolidating its 454 and NimbleGen products into a new sequencing unit that will cover both life science and clinical diagnostic applications.

The changes are part of the company's decision, announced today, to dissolve Roche Applied Science, the life science unit of its Diagnostics division, by the end of this year and to integrate Applied Science's products with other units.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Feb
21
Sponsored by
Oracle Health Sciences

This webinar will cover best practices for integrating data from multiple clinical and genomic sources for clinical decision support.